Polycystic liver disease ( PLD ) , the most common extrarenal manifestation of autosomal-dominant polycystic kidney disease ( ADPKD ) , has become more prevalent as a result of increased life expectancy , improved renal survival , reduced cardiovascular mortality , and renal replacement therapy .